Catherine Blakespear Legislator I'm sorry, I just want to make sure I'm accurately following along
#GLP1 #Pharma #Strategy #MarketAccess #PharmaGambit To view or add a comment, sign in Great post Alexis - bang on the money
Recovery is simple, not easy
For example, UnitedHealthcare Communications (2025) detail PA criteria for its MA dual-eligible OneCare plans: Zepbound (tirzepatide) was placed on the preferred drug list in MA effective 2025, but still requires PA ( [13] )
Despite their popularity, patients need to understand the side effects associated with these drugs
Additionally, semaglutide slows gastric emptying, which means food moves more slowly from the stomach into the small intestine, contributing to improved glycaemic control and increased satiety